NCT01432015: Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting |
|
|
| Completed | 4 | 20 | US | fosaprepitant, Emend IV, aprepitant, Emend, Oral Placebo, IV placebo, Normal Saline | Gynecologic Oncology Associates, Merck Sharp & Dohme LLC | Ovarian Cancer, Uterine Cancer | 03/15 | 03/15 | | |
